N/A
N/ASpecific product details are not publicly available. The company name suggests a generative AI platform or service for chronic disease management, but no official product has been announced.
—
No Form D filings on record
ChronicGPT Inc. is an early-stage healthtech venture incorporated in Texas in June 2025. The company operates at the intersection of artificial intelligence and healthcare, with its name suggesting a focus on applying generative AI to the field of chronic disease management. Based on recent regulatory filings, the company is in its initial fundraising and operational phase.
What sets it apart
The company's focus appears to be on leveraging generative AI specifically for managing chronic diseases, a specialized niche within the broader healthtech AI market.
Specific product details are not publicly available. The company name suggests a generative AI platform or service for chronic disease management, but no official product has been announced.